Arno Therapeutics
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
$15.0m | Post IPO Equity | ||
$31.0m | Post IPO Equity | ||
$7.4m | Post IPO Equity | ||
$8.0m | Post IPO Equity | ||
Total Funding | - |
Recent News about Arno Therapeutics
EditArnothera operates in the financial services sector, focusing on retirement planning and investment strategies. The company primarily serves individuals looking to secure their financial future by converting their 401k plans into Gold IRAs. This niche market includes clients who are interested in diversifying their retirement portfolios with physical precious metals. Arnothera's business model revolves around providing detailed guidance and support throughout the conversion process, ensuring clients choose reputable custodians and understand the steps involved. The company generates revenue through advisory fees and commissions from partnering custodians. By offering a specialized service, Arnothera aims to provide financial security and peace of mind for its clients as they approach retirement.
Keywords: Gold IRA, 401k conversion, retirement planning, financial security, investment strategies, precious metals, custodians, advisory fees, niche market, portfolio diversification.